{
    "2020-01-29": [
        [
            {
                "time": "2018-01-02",
                "original_text": "5 Top Non-Tech Earnings Charts",
                "features": {
                    "keywords": [
                        "Non-Tech",
                        "Earnings",
                        "Charts"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "non-tech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-03-15",
                "original_text": "Alkermes' (ALKS) NDA for ALKS 3831 Accepted by FDA for Review",
                "features": {
                    "keywords": [
                        "Alkermes",
                        "NDA",
                        "FDA",
                        "Review"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-01-25",
                "original_text": "Big Drug/Biotech Stock Earnings on Jan 30: BIIB, ALXN & More",
                "features": {
                    "keywords": [
                        "Drug",
                        "Biotech",
                        "Stock",
                        "Earnings",
                        "BIIB",
                        "ALXN"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "biotech",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-04-24",
                "original_text": "Eli Lilly Reports Earnings Tomorrow. Hereâ€™s What to Expect.",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Earnings",
                        "Tomorrow",
                        "Expect"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-05-10",
                "original_text": "CVS to offer diabetes drugs at no out-of-pocket costs for PBM members",
                "features": {
                    "keywords": [
                        "CVS",
                        "diabetes",
                        "drugs",
                        "out-of-pocket",
                        "PBM",
                        "members"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-20",
                "original_text": "Lilly Receives FDA Priority Review for the Selpercatinib New Drug Application",
                "features": {
                    "keywords": [
                        "Lilly",
                        "FDA",
                        "Priority",
                        "Review",
                        "Selpercatinib",
                        "New Drug Application"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}